Synopsis
There has been increasing interest in quantitative
methods to excavate more information than traditional descriptive features,
facilitated by the availability of texture analysis software platforms. By
doing whole-tumor histogram-based texture analysis on pre-treatment ADC map,
histogram parameters reflecting the pixel distribution of ROIs were derived. Our
study found that LARC that achieved pCR after NCRT appeared less heterogeneous
on ADC map and had lower high percentile pre-treatment ADC values. Whole-tumor histogram parameters of pre-treatment ADC map were feasible
to predict pCR in LARC, including the absolute value of relative deviation, frequency size, quantile 75%, 90%, and 95% of ADC value histogram.
Introduction
Neoadjuvant chemoradiotherapy (NCRT) following
with total mesorectal excision a period later has become the standard of care
for the locally advanced rectal cancer (LARC). Some patients can even achieve a
pathological complete response (pCR) after NCRT, associated with an improved
local control, and increased disease-free survival. Although
still controversial, a “wait and watch” policy or a more conservative surgical
treatment has been proposed for patients with complete response. 1, 2 Various preoperative variables
have been used to predict the grade of tumor response after NCRT but with inconsistent
results. It is now acknowledged that tumors may demonstrate considerable
biologic heterogeneity that influences their clinical outcome, which can be
reflected on medical images. There has been increasing interest in quantitative
methods to excavate more information than traditional descriptive features,
facilitated by the availability of texture analysis software platforms. 3, 4 Few previous studies have
investigated the relationship between patient's outcome after NCRT
and tumor heterogeneity assessed by histogram-based texture analysis on
pre-treatment ADC map.This study aims to determine the diagnostic performance of ADC map before treatment in predicting pCR after NCRT in LARC by using whole-tumor
histogram-based texture analysis.Methods
34 patients
with LARC (cT3/4 or N+) who have completed neoadjuvant CRT and subsequent surgery
were enrolled retrospectively. Histopathologic tumor regression
grade was the reference standard. No remaining viable cancer cells in specimen
was graded as pathological complete regression (pCR). ROIs covering the whole
tumor were manually drawn twice (two weeks interval) on pre-treatment ADC map (b-values: 0, 1000 s/mm2) by one radiologist, blinded to the
pathology results, and with T2W and DWI imaging on high b value being the reference. For texture analysis, histogram-based parameters were
extracted from the pixel values on ADC map. The intraclass correlation
coefficient (ICC) was used to evaluate intraobserver variability. Independent t
test was used to compare histogram parameters between pCR and non-pCR group. The
diagnostic performance of pre-treatment ADC map for the prediction of pCR was
evaluated with receiver operating characteristics (ROC) analysis.Results
For both measurements, the standard
deviation (P1=0.003, P2=0.005), variance (P1=0.006,
P2=0.006), range (P1=0.016, P2=0.022), absolute value of relative deviation (P1=0.002, P2=0.005), entropy (P1=0.019,
P2=0.022), frequency size (P1=0.006, P2=0.006), quantile 75% (P1=0.024, P2=0.032), quantile 90% (P1=0.01,
P2=0.01) and quantile 95% (P1=0.005, P2=0.004) of whole-tumor pre-treatment ADC values were significantly lower in pCR group.
And the uniformity of positive pixel distribution (UPP, P1=0.021, P2=0.028)
and energy (P1=0.021, P2=0.028) were higher than non-pCR
group. Since the intraobserver agreement was good for the absolute value of relative deviation (ICC=0.975,
95%CI: 0.95-0.987), frequency size (ICC=0.976, 95%CI: 0.954-0.988), quantile 75%
(ICC=0.964, 95%CI: 0.93-0.982), 90% (ICC=0.933, 95%CI: 0.871-0.966) and 95%
(ICC=0.867, 95%CI: 0.752-0.931), the first time measurement was employed to
following ROC analysis. Respective AUCs of the absolute value of relative deviation, frequency size, quantile
75%, 90% and 95%of ADC value histogram when predicting pCR were 0.829, 0.821, 0.743, 0.757 and
0.779, with the optimal cut-off point of 1.187 (sensitivity=70%,
specificity=92.9%), 1.323 (sensitivity=70%, specificity=92.9%), 1.046×10-3mm2/s (sensitivity=80%, specificity=71.4%), 1.203×10-3mm2/s
(sensitivity=80%, specificity=71.4%), and 1.337×10-3mm2/s (sensitivity=75%, specificity=78.6%) respectively.Discussion
In this limited population study, a number of whole-tumor
histogram-based texture parameters of ADC map before onset of NCRT were
significantly different between pCR and non-pCR LARC patients. Absolute value of relative deviation, frequency size, quantile 75%, 90%, and 95% of baseline ADC value histogram could feasibly predict patients who were likely to
achieve pCR after NCRT. Histogram-based texture parameters were determined by
the way the signal intensities were distributed over the pixels in ROIs.
Generally, higher entropy, lower energy, higher dispersed distribution of pixel
histogram represent higher heterogeneity. 5 The present study revealed
that patients who achieved pCR had relatively less heterogeneous distribution
of baseline ADC values in contrast with non-pCR. In addition, high quantile (75%, 90%, and 95%) ADC values were predictive for pCR, with a respective AUC of 0.743, 0.757 and 0.779. Possible explanation is that tumors
with higher high percentile pre-treatment ADC values are likely to be more
necrotic, which may be correlated to poorer tissue perfusion, a more acidic
micro-environment, and a lower oxygen concentration, leading to a higher possibility
to treatment resistance.Conclusion
Locally advanced rectal cancer that achieved
pCR after NCRT appeared less heterogeneous on pre-treatment ADC map and had lower high percentile ADC values. Whole-tumor texture analysis based on
histogram parameters of pre-treatment ADC map were feasible to predict pCR in
LARC. Acknowledgements
No acknowledgement found.References
1. Habr-Gama
A, Perez R O, Nadalin W, et al.
Operative versus nonoperative treatment for stage 0 distal rectal cancer
following chemoradiation therapy: long-term results. Ann Surg, 2004,
240:711-717; discussion 717-718.
2. Maas
M, Beets-Tan R G, Lambregts D M, et al.
Wait-and-see policy for clinical complete responders after chemoradiation for
rectal cancer. J Clin Oncol, 2011, 29:4633-4640.
3. Lisson
C S, Lisson C G, Flosdorf K, et al.
Diagnostic value of MRI-based 3D texture analysis for tissue characterisation
and discrimination of low-grade chondrosarcoma from enchondroma: a pilot study.
Eur Radiol, 2017. 10.1007/s00330-017-5014-6.
4. Beresova
M, Larroza A, Arana E, et al. 2D and
3D texture analysis to differentiate brain metastases on MR images: proceed
with caution. Magma, 2017. 10.1007/s10334-017-0653-9.
5. Kim
J H, Ko E S, Lim Y, et al. Breast
Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes.
Radiology, 2017, 282:665-675.